3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Head and Neck Neoplasms
1
Interventions
Cisplatin
47
Radiotherapy
37
Fluorouracil
23
Cetuximab
17
pembrolizumab
11
Carboplatin
11
Paclitaxel
8
Docetaxel
8
Radiotherapy, Intensity-Modulated
6
Chemotherapy, Adjuvant
6
Surgical Procedures, Operative
5
Standard of Care
5
nimotuzumab
4
Methotrexate
4
Gabapentin
4
Drug Therapy
4
Afatinib
4
Radiotherapy, Conformal
3
Radiation
3
Porfiromycin
3
Nivolumab
3
Neoadjuvant Therapy
3
Fibroblast Growth Factor 7
3
Bleomycin
3
zalutumumab
2
sargramostim
2
epacadostat
2
Tranexamic Acid
2
Tirapazamine
2
Pilocarpine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Head and Neck Neoplasms
×
combretastatin
×
Clear all
NCT01701349
2014-05-01
FACT2
Mateon Therapeutics
Phase 3
Withdrawn